BlackRock Fund Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$128M	Buy	7,891,641 +838,740	+12%	+$15.2M	0.02%	1013
2016 Q3	$128M	Buy	7,052,901 +374,765	+6%	+$7.32M	0.03%	893
2016 Q2	$110M	Buy	6,678,136 +3,740,449	+127%	+$60.5M	0.02%	898
2016 Q1	$48.7M	Buy	2,937,687 +208,391	+8%	+$3.65M	0.01%	1475
2015 Q4	$59.1M	Sell	2,729,296 -310,832	-10%	-$6.05M	0.01%	1363
2015 Q3	$60.3M	Buy	3,040,128 +1,010,150	+50%	+$31.9M	0.02%	1292
2015 Q2	$70.5M	Buy	+2,029,978	New	+$61.9M	0.02%	1275
2014 Q3	–	Sell	-2,303,695	Closed	-$36.4M	–	3908
2014 Q2	$36.4M	Sell	2,303,695 -33,043	-1%	-$472K	0.01%	1617
2014 Q1	$35.3M	Buy	2,336,738 +177,664	+8%	+$2.01M	0.01%	1642
2013 Q4	$16.5M	Buy	2,159,074 +699,267	+48%	+$3.77M	0.01%	2097
2013 Q3	$4.89M	Buy	1,459,807 +154,431	+12%	+$407K	﹤0.01%	2824
2013 Q2	$3.21M	Buy	+1,305,376	New	+$3.13M	﹤0.01%	2951